Vaccination Against Respiratory Syncytial Virus in Pregnancy: A Suitable Tool to Combat Global Infant Morbidity and Mortality?
This article, published in The Lancet Infectious Diseases, describes the epidemiological and immunological background of respiratory syncytial virus (RSV) infection and the pipeline of RSV vaccines in development. It discusses the potential for implementation of a safe and immunogenic RSV vaccine in regards to a range of strategies, including maternal immunization. It also summarizes key outstanding issues for researchers and policymakers to understand factors affecting the design and distribution of a successful RSV vaccine.
Author: Saso A, Kampmann B
» Visit web page (English)
(Located at www.thelancet.com)
Citation: Saso A, Kampmann B. Vaccination Against Respiratory Syncytial Virus in Pregnancy: A Suitable Tool to Combat Global Infant Morbidity and Mortality? The Lancet Infectious Diseases. 2016;16(8):e153-e163.
Resource types: Peer-reviewed journal
Diseases/vaccines: Respiratory syncytial virus (RSV)